A detailed history of Jefferies Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Jefferies Group LLC holds 224,984 shares of PFE stock, worth $6.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
224,984
Previous 154,657 45.47%
Holding current value
$6.3 Million
Previous $8.11 Million 21.42%
% of portfolio
0.1%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

BUY
$43.76 - $53.42 $3.08 Million - $3.76 Million
70,327 Added 45.47%
224,984 $9.85 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.84 Million - $3.47 Million
64,995 Added 38.56%
233,532 $9.84 Million
Q2 2022

Sep 21, 2023

BUY
$46.53 - $55.17 $5.19 Million - $6.15 Million
111,507 Added 258.42%
154,657 $8.11 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $5.34 Million - $6.34 Million
114,841 Added 213.87%
168,537 $8.17 Million
Q1 2022

Sep 21, 2023

BUY
$45.75 - $56.69 $1.97 Million - $2.45 Million
43,144 Added 719066.69%
43,150 $2.23 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $2.46 Million - $3.04 Million
53,690 Added 894833.31%
53,696 $2.21 Million
Q4 2021

Sep 21, 2023

SELL
$41.32 - $61.25 $10.3 Million - $15.2 Million
-248,887 Reduced 100.0%
6 $0
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $10.3 Million - $15.2 Million
-248,887 Reduced 100.0%
6 $0
Q3 2021

Sep 21, 2023

BUY
$39.25 - $50.42 $1.79 Million - $2.3 Million
45,549 Added 22.4%
248,893 $10.7 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $1.79 Million - $2.3 Million
45,549 Added 22.4%
248,893 $10.7 Million
Q2 2021

Sep 21, 2023

SELL
$35.91 - $40.68 $2.52 Million - $2.85 Million
-70,147 Reduced 25.65%
203,344 $7.96 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $2.52 Million - $2.85 Million
-70,147 Reduced 25.65%
203,344 $7.96 Million
Q1 2021

Sep 21, 2023

SELL
$33.49 - $37.77 $7.41 Million - $8.35 Million
-221,137 Reduced 44.71%
273,491 $9.91 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $7.41 Million - $8.35 Million
-221,137 Reduced 44.71%
273,491 $9.91 Million
Q4 2020

Sep 21, 2023

BUY
$33.47 - $42.56 $8.74 Million - $11.1 Million
261,096 Added 111.8%
494,628 $18.2 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $5.16 Million - $6.57 Million
154,283 Added 45.33%
494,628 $18.2 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $6.94 Million - $8.14 Million
218,577 Added 179.5%
340,345 $12.5 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $1.18 Million - $1.43 Million
-39,049 Reduced 24.28%
121,768 $3.98 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $1.54 Million - $2.2 Million
-57,093 Reduced 26.2%
160,817 $5.25 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $4.06 Million - $4.6 Million
123,253 Added 130.21%
217,910 $8.54 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $1.44 Million - $1.87 Million
-44,303 Reduced 31.88%
94,657 $3.4 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $3.97 Million - $4.45 Million
107,222 Added 337.83%
138,960 $6.02 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $7.91 Million - $8.69 Million
-211,039 Reduced 86.93%
31,738 $1.35 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $6.87 Million - $7.84 Million
178,710 Added 278.94%
242,777 $10.6 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $94,758 - $114,935
2,749 Added 4.48%
64,067 $2.82 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $2.59 Million - $2.77 Million
-78,679 Reduced 56.2%
61,318 $2.23 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $1.89 Million - $2.19 Million
-59,220 Reduced 29.73%
139,997 $4.97 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $15.9 Million - $16.9 Million
-479,450 Reduced 70.65%
199,217 $7.22 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $21 Million - $23.2 Million
678,667
678,667 $24.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.